NETILMICIN EYE DROPS (Nettacin®)
Clinical Indication
Topical treatment of external infections of the eye and its adnexa caused by netilmicin sensitive bacteria
Date of classification
October 2022
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.